ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin
Open Access
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Journal of Lipid Research
- Vol. 45 (4) , 653-656
- https://doi.org/10.1194/jlr.m300278-jlr200
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- ATP binding cassette G5 C1950G polymorphism may affect blood cholesterol concentrations in humansClinical Genetics, 2002
- Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterolJournal of Clinical Investigation, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Accumulation of Dietary Cholesterol in Sitosterolemia Caused by Mutations in Adjacent ABC TransportersScience, 2000
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Comparison of One-Year Efficacy and Safety of Atorvastatin Versus Lovastatin in Primary HypercholesterolemiaThe American Journal of Cardiology, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapyAtherosclerosis, 1995
- Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of diseaseThe Lancet, 1994